| Microsatellite instability as a biomarker for PD-1 blockade JC Dudley, MT Lin, DT Le, JR Eshleman Clinical Cancer Research 22 (4), 813-820, 2016 | 887 | 2016 |
| Early detection of molecular residual disease in localized lung cancer by circulating tumor DNA profiling AA Chaudhuri, JJ Chabon, AF Lovejoy, AM Newman, H Stehr, TD Azad, ... Cancer discovery 7 (12), 1394-1403, 2017 | 833 | 2017 |
| Detection and surveillance of bladder cancer using urine tumor DNA JC Dudley, J Schroers-Martin, DV Lazzareschi, WY Shi, SB Chen, ... Cancer discovery 9 (4), 500-509, 2019 | 167 | 2019 |
| Detection of solid tumor molecular residual disease (MRD) using circulating tumor DNA (ctDNA) RI Chin, K Chen, A Usmani, C Chua, PK Harris, MS Binkley, TD Azad, ... Molecular diagnosis & therapy 23 (3), 311-331, 2019 | 155 | 2019 |
| Impact of next-generation sequencing on the clinical diagnosis of pancreatic cysts M Jones, Z Zheng, J Wang, J Dudley, E Albanese, A Kadayifci, ... Gastrointestinal endoscopy 83 (1), 140-148, 2016 | 140 | 2016 |
| Next‐generation sequencing adds value to the preoperative diagnosis of pancreatic cysts MW Rosenbaum, M Jones, JC Dudley, LP Le, AJ Iafrate, MB Pitman Cancer Cytopathology 125 (1), 41-47, 2017 | 114 | 2017 |
| Next-generation sequencing and fluorescence in situ hybridization have comparable performance characteristics in the analysis of pancreaticobiliary brushings for malignancy JC Dudley, Z Zheng, T McDonald, LP Le, D Dias-Santagata, D Borger, ... The Journal of Molecular Diagnostics 18 (1), 124-130, 2016 | 90 | 2016 |
| Early detection of molecular residual disease in localized lung cancer by circulating tumor DNA profiling. Cancer Discov. 2017; 7: 1394–1403. doi: 10.1158/2159-8290 AA Chaudhuri, JJ Chabon, AF Lovejoy, AM Newman, H Stehr, TD Azad, ... CD-17-0716.[Europe PMC free article][Abstract][CrossRef][Google Scholar], 0 | 85 | |
| Performance characteristics of next-generation sequencing in clinical mutation detection of colorectal cancers L Haley, LH Tseng, G Zheng, J Dudley, DA Anderson, NS Azad, ... Modern Pathology 28 (10), 1390-1399, 2015 | 66 | 2015 |
| Multiregion whole-exome sequencing of intraductal papillary mucinous neoplasms reveals frequent somatic KLF4 mutations predominantly in low-grade regions K Fujikura, W Hosoda, M Felsenstein, Q Song, JG Reiter, L Zheng, ... Gut 70 (5), 928-939, 2021 | 62 | 2021 |
| Non-p.V600E BRAF Mutations Are Common Using a More Sensitive and Broad Detection Tool J Carter, LH Tseng, G Zheng, J Dudley, P Illei, CD Gocke, JR Eshleman, ... American journal of clinical pathology 144 (4), 620-628, 2015 | 57 | 2015 |
| Detection of low-frequency DNA variants by targeted sequencing of the Watson and Crick strands JD Cohen, C Douville, JC Dudley, BJ Mog, M Popoli, J Ptak, L Dobbyn, ... Nature biotechnology 39 (10), 1220-1227, 2021 | 51 | 2021 |
| Early detection of molecular residual disease in localized lung cancer by circulating tumor DNA profiling. Cancer Discov. 2017; 7 (12): 1394–403 AA Chaudhuri, JJ Chabon, AF Lovejoy, AM Newman, H Stehr, TD Azad, ... doi. org/10.1158/2159-8290. Cd-17-0716, 2017 | 46 | 2017 |
| Challenges Posed to Pathologists in the Detection of KRAS Mutations in Colorectal Cancers J Dudley, LH Tseng, L Rooper, M Harris, L Haley, G Chen, CD Gocke, ... Archives of Pathology and Laboratory Medicine 139 (2), 211-218, 2015 | 45 | 2015 |
| Preoperative characteristics and cytological features of 136 histologically confirmed pancreatic mucinous cystic neoplasms A Scourtas, JC Dudley, WR Brugge, A Kadayifci, M Mino‐Kenudson, ... Cancer Cytopathology 125 (3), 169-177, 2017 | 39 | 2017 |
| Tumor cellularity as a quality assurance measure for accurate clinical detection of BRAF mutations in melanoma JC Dudley, GT Gurda, LH Tseng, DA Anderson, G Chen, JM Taube, ... Molecular diagnosis & therapy 18, 409-418, 2014 | 38 | 2014 |
| Deactivated CRISPR associated protein 9 for minor-allele enrichment in cell-free DNA A Aalipour, JC Dudley, S Park, S Murty, JJ Chabon, EA Boyle, M Diehn, ... Clinical chemistry 64 (2), 307-316, 2018 | 37 | 2018 |
| The Liquid Biopsy Consortium: Challenges and opportunities for early cancer detection and monitoring SM Batool, A Yekula, P Khanna, T Hsia, AS Gamblin, E Ekanayake, ... Cell Reports Medicine 4 (10), 2023 | 30 | 2023 |
| Broken words: The abuse of science and faith in American politics J Dudley Crown, 2011 | 28 | 2011 |
| Detection and diagnostic utilization of cellular and cell-free tumor DNA JC Dudley, M Diehn Annual Review of Pathology: Mechanisms of Disease 16 (1), 199-222, 2021 | 20 | 2021 |
